Revelation Biosciences shareholders approved board authority for reverse stock split range up to 1-for-250

Revelation Biosciences

Revelation Biosciences

REVB

0.00
  • Revelation Biosciences held its annual shareholder meeting on June 24, 2026.
  • Shareholders backed a board mandate to carry out one or more reverse stock splits within one year, at ratios from 1-for-2 to 1-for-250.
  • The reverse split authority was discretionary; any split still requires a separate board decision on timing and the specific ratio.
  • Shareholders ratified Baker Tilly US, LLP as independent auditor for the fiscal year ending Dec. 31, 2026.
  • A director nominee, Jennifer Carver, was elected.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revelation Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-281200), on June 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.